What this means
Researchers tracked people over time to see if a biological age score predicted mild memory and thinking problems. Lower biological age went with fewer mild thinking problems, but this study cannot prove cause.
Plain-English summary written by an AI model from the abstract. The original is below.
- Who it was tested in
- 9,410 middle-aged and older adults in China
- Kind of research
- A study
The science
- Original title
- Association between Gompertz law-based biological age (GOLD BioAge) and incident mild cognitive impairment: Modifying role of social activeness.
- Authors
- Xiao Y, Li L
- Journal
- Journal of Alzheimer's disease reports
- Published
- Oct 15, 2026
- Study type
- Study
- PMID
- 42876926 ↗
Abstract
Background
Mild cognitive impairment (MCI) is an important transitional stage between normal cognitive aging and dementia. Biomarker-based biological age may better capture physiological aging processes than chronological age, yet its association with the risk of developing MCI remains insufficiently studied. We aimed to examine the association between Gompertz Law-Based Biological Age (Light BioAge) and incident MCI in a middle-aged and older Chinese population, and to explore whether social activeness modifies this association.
What they did
We used data from the China Health and Retirement Longitudinal Study, a nationally representative cohort. Light BioAge was calculated from chronological age, serum creatinine, fasting glucose, and C-reactive protein. Incident MCI was defined using age- and education-standardized cognitive assessments. Cox regressions were used to analysis.
What they found
Among 9410 participants free of MCI at baseline, 1047 developed MCI during follow-up. Light BioAge was negatively associated with risk of MCI (hazards ratio (HR) = 0.99, 95% CI: 0.98-0.99). Compared to high Light BioAge, those in the moderate and low groups showed significantly lower risks of MCI (HR = 0.78, 95% CI: 0.65-0.94 and HR = 0.79, 95% CI: 0.65-0.97, respectively). The association were consistent across sex and different levels of social activeness, with no significant interaction observed. Lower biological age, as estimated by Light BioAge, is independently associated with a reduced risk of MCI in middle-aged and older adults. The use of biomarker-based aging indicators may help identify individuals at higher risk of cognitive decline for early preventive strategies.
The authors' abstract, grouped under plain headings from its own section labels.
Xiao Y, Li L Association between Gompertz law-based biological age (GOLD BioAge) and incident mild cognitive impairment: Modifying role of social activeness. Journal of Alzheimer's disease reports. 2026. doi:10.1177/25424823261470071. PMID: 42876926. https://pubmed.ncbi.nlm.nih.gov/42876926/